Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF 121/rGel

Investigative Radiology

Volumn 46, Issue 7, 2011, Pages 441-449

  Cho, Eun Jin ^a,b   Yang, Jaemoon ^a   Mohamedali, Khalid A ^c   Lim, Eun Kyung ^b   Kim, Eun Jung ^b   Farhangfar, Carol J ^c   Suh, Jin Suck ^a   Haam, Seungjoo ^b   Rosenblum, Michael G ^c   Huh, Yong Min ^a,d  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Angiogenesis; Contrast agent; Magnetic resonance; Nanoparticles

Indexed keywords

DODECYLAMINE; LAURIC ACID; MANGANESE DERIVATIVE; NANOCRYSTAL; NANOPARTICLE; VASCULOTROPIN 121; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; ELECTRON MICROSCOPY; EX VIVO STUDY; FLUORESCENCE IMAGING; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 79959926354     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182174fad     Document Type: Article

References (19)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70. (Pubitemid 30046295)
2. Tabernero J. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res. 2007;5:203-220. (Pubitemid 46569773)
3. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581-611. (Pubitemid 39099316)
4. Ahmad SA, Jung YD, Liu W, et al. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis. Semin Cancer Biol. 2002;12:105-112. (Pubitemid 34680739)
5. Mohamedali KA, Kedar D, Sweeney P, et al. The vascular-targeting fusion toxin VEGF121/rgel inhibits the growth of orthotopic human bladder carcinoma tumors. Neoplasia 2005;7:912-920.
6. Torisu H, Ono M, Kiryu H, et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF-alpha and IL-1 alpha. Int J Cancer. 2000;85:182-188. (Pubitemid 30023065)
7. Cai W, Chen K, Mohamedali KA, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med. 2006;47:2048-2056. (Pubitemid 47544993)
8. Hsu AR, Cai W, Veeravagu A, et al. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med. 2007;48:445-454. (Pubitemid 47604931)
9. Anderson CR, Rychak JJ, Backer M, et al. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol. 2010;45:579-585.
10. Pochon S, Tardy I, Bussat P, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol. 2010;45:89-95.
11. Lijowski M, Caruthers S, Hu G, et al. High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model. Invest Radiol. 2009;44:15-22.
12. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452:580-589. (Pubitemid 351483372)
13. Lee JH, Huh YM, Jun. YW, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007;13:95-99.
14. Huh YM, Jun. YW, Song HT, et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc. 2005;127:12387-12391.
15. Yang J, Lee CH, Ko HJ, et al. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew Chem Int Ed Engl. 2007;46:8836-8839. (Pubitemid 350207937)
16. Yang J, Lim EK, Lee HJ, et al. Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection. Biomaterials. 2008;29:2548-2555.
17. Yang J, Lee TI, Lee J, et al. Synthesis of ultrasensitive magnetic resonance contrast agents for cancer imaging using PEG-fatty acid. Chem Mater. 2007;19:3870-3876. (Pubitemid 47266080)
18. Lee J, Yang J, Seo SB, et al. Smart nanoprobes for ultrasensitive detection of breast cancer via magnetic resonance imaging. Nanotechnology. 2008;19:485101.
19. Kamat AM, Karashima T, Davis DW, et al. The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. Mol Cancer Ther. 2004;3:279.